Cancer research on extract of Desmostachya bipinnata
Best insight from top research papers
Cancer research on the extract of Desmostachya bipinnata has been conducted in several studies. The plant has been found to have potential anti-cancer properties. One study isolated a compound from the methanolic extract of Desmostachya bipinnata, which exhibited inhibitions of signal transducer and activator of transcription 3-dependent luciferase activity in HCT-116 colon cancer cell line . Another study mentioned that Desmostachya bipinnata is used as an anti-breast cancer drug . Additionally, the plant has been reported to have cytotoxic activity, which is relevant in cancer research . These findings suggest that Desmostachya bipinnata may have potential as a natural therapy agent for cancer treatment. Further research is needed to explore its full potential and understand the mechanisms behind its anti-cancer effects.
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| The paper mentions that the compound isolated from Desmostachya bipinnata exhibited inhibition of signal transducer and activator of transcription 3 (STAT3) in a colon cancer cell line. However, it does not specifically mention cancer research on the extract of Desmostachya bipinnata. | |
| The paper mentions that an in vitro cytotoxic study was conducted on human laryngeal epithelial carcinoma cells (Hep-2), human cervical cancer cell line (HeLa), and NIH 3T3 using an extract of Desmostachya bipinnata. The extract showed cytotoxic potential against the cancer cell lines. | |
3 Citations | The paper does not mention any research on the extract of Desmostachya bipinnata specifically for cancer. The paper focuses on the bioactivity screening of the plant extract for antimicrobial and antioxidant activities. |
3 Citations | The provided paper does not mention any cancer research on the extract of Desmostachya bipinnata. |
13 Citations | The provided paper does not mention any research on the extract of Desmostachya bipinnata specifically related to cancer. |
Related Questions
What are the current research findings on the use of plant extracts for breast cancer treatment?4 answersCurrent research findings suggest that plant extracts hold promise in breast cancer treatment. Studies have shown that various plants exhibit anti-breast cancer properties, with some extracts demonstrating cytotoxic effects on breast cancer cell lines while sparing normal cells. Phytotherapy, as an adjuvant therapy, has shown significant results in combination with conventional medicines, potentially reducing side effects and treatment costs. Additionally, research highlights the importance of screening phytochemical components of medicinal plants to identify those with potent anticancer activities against different types of breast cancer cell lines. The use of plant extracts like those from Alpina galaga, Urtica dioica, and Nigella sativa has shown promising anticancer effects by inhibiting cell proliferation and inducing cell death in preclinical models.
Anti cancer activity of Cannabis sativa's extract?5 answersCannabis sativa extracts have shown promising anti-cancer activity in various studies. Different extracts rich in cannabinoids like Cannabidiol (CBD) have demonstrated effectiveness in inhibiting cancer cell growth and inducing cell death in cancers such as head and neck squamous cell carcinoma (HNSCC). Additionally, the presence of terpenes in Cannabis sativa extracts, such as β-caryophyllene, limonene, and myrcene, has also been linked to potential anti-tumor effects in colorectal cancer (CRC). Furthermore, the synergistic effects of cannabinoids and terpenes have been highlighted as crucial factors in the treatment of CRC. These findings underscore the importance of further research to fully understand the mechanisms of action and safety profiles of Cannabis sativa compounds for anti-cancer therapies.
Isolation of compounds from plants used for skin cancer5 answersIsolation of compounds from plants used for skin cancer has been a focus of research. Several studies have identified active compounds from medicinal plants that show potential in treating melanoma and non-melanoma skin cancers. These compounds have been isolated through various techniques such as VLC, preparative TLC, and fractionation using normal phase silica gel. Some of the compounds that have been identified include ursolic acid and a closely related compound. In vitro studies have also shown that plant extracts can reduce cell viability, induce apoptosis, and inhibit angiogenesis, invasion, and metastasis in melanoma skin cancer. The mechanisms of action of these compounds involve the promotion of caspase activity, inhibition of cell proliferation, and inhibition of tumor promoting proteins. Further research is needed to explore more plants, their active compounds, and the mechanisms of action for the development of standard herbal medicines.
2.1What is Medicinal Plants in Cancer Treatment?3 answersMedicinal plants in cancer treatment refer to the use of plants and their bioactive compounds for preventing, impeding, delaying, or curing cancer. These plants have been used in traditional medicine systems for thousands of years and are considered a repository of various bioactive compounds with therapeutic properties. They have shown potential roles in cancer treatment, with some plant-derived compounds already in clinical use worldwide. Medicinal plants have been found to have cytotoxic abilities against various types of cancer, including breast cancer and colorectal cancer. These bioactive compounds can affect cell cycle regulation, initiate apoptosis, and affect cell signaling pathways. Phytotherapy, which involves the use of herbal preparations, is a promising approach in the treatment of breast cancer, either as adjuvant therapy or in combination with conventional medicines. The search for new bioactive substances in the treatment of breast cancer is ongoing, and the standard methods for the preparation of herbal products need to be determined.
How is bio-guided fractionation of natural compounds used for cancer research?5 answersBio-guided fractionation of natural compounds is used in cancer research to identify and isolate active fractions or compounds from plant extracts that exhibit anticancer activity. This process involves the screening and purification of phytoconstituents from crude extracts to identify the most active fractions. The active fractions are then further characterized using analytical techniques such as UPLC-HRMS/MS, LC-MS/MS, and NMR to determine the putative compounds responsible for the bioactivity. These compounds can be phenolic compounds, flavonoids, organic acids, or other bioactive molecules. The identified compounds can then be evaluated for their cytotoxic effects against cancer cells using in vitro assays. This approach allows for the discovery of natural compounds with potential anticancer properties, which can be further studied and developed for pharmaceutical applications in cancer treatment.
What are the cancer drugs from plant source?3 answersPlant-based drugs have shown potential for the treatment of cancer. Some of the cancer drugs derived from plants include podophyllotoxin (teniposide and etoposide), taxanes (docetaxel and paclitaxel), and vinca alkaloids (vincristine, vinorelbine, vindesine, and vinblastine). Other plant-derived compounds with promising anticancer activity include curcumin, piperine, allicin, quercetin, resveratrol, boswellic acid, sulforaphane, and ginsenoside. Natural products such as topotecan, taxol, and vinca alkaloids (vincristine, vinblastine, vinorelbine, and vindesine) are widely used as anticancer agents. Additionally, there are several plant-derived compounds currently in clinical trials as potential cancer chemotherapeutic agents, including bisindole alkaloids, podophyllotoxin lignan analogs, and taxane diterpenoid derivatives. Phytochemicals like paclitaxel, vinblastine, vincristine, and camptothecin are successfully used in clinical practice, highlighting the importance of plants in cancer chemotherapy.